LONDON - A pill that could spell the end of type one diabetes has been created by researchers.
FDA warns of faulty results with blood sugar tests
WASHINGTON — The Food and Drug Administration is warning diabetes patients that certain blood sugar tests can give inaccurate results in patients taking other medications.
NEW DELHI - A leading diabetologist, Dr. Vikas Ahluwalia, has said people suffering from diabetes need to be aware of the dangers and risks posed by metabolic syndrome, but adds that while it is a lifelong condition, lifestyle changes can help to reverse it or reduce the risk factors.
WASHINGTON - Experts at UT Southwestern Medical Center say that the fear about weight gain, which often cause type 2 diabetes patients to resist taking insulin, is largely unfounded.
WASHINGTON - Hopes have been raised of a new treatment to free thousands of diabetes sufferers from the burden of daily needle injections.
WASHINGTON - Insufficient sleep may contribute to the development of insulin resistance and reduced glucose tolerance, which in turn may increase the long-term risk of diabetes, concludes a new study.
Denmark’s Novo Nordisk posts rise in 2Q profits
COPENHAGEN — Danish drug maker Novo Nordisk A/S on Thursday said second-quarter net profit rose by 21 percent, aided by a surge in insulin sales in North America.
WASHINGTON - Scientists have found that non-invasive imaging (MRI) may aid physicians in the early diagnosis, staging and treatment of diabetes.
WASHINGTON - Short sleep times may contribute to the development of insulin resistance and reduced glucose tolerance, which in turn may elevate the risk of diabetes, concludes a new study.
WASHINGTON - A commonly prescribed anti-diabetic drug can reduce an individual’s risk of developing pancreatic cancer by 62 percent, according to a new study.